BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

BioNews
Biotechnology, Pharmaceutical and Life Science News
search help

Search Results

Documents 1-25 out of 56 found
  Current Search:  tick: 224, bites: 56     

HTML
55%
Another Sutent Trial Bites the Dust for Pfizer
Another late-stage trial with Pfizers Sutent has been called off.

This time an evaluation of Sutent plus Folfiri versus Folfiri alone as a first-line treatment of metastatic colorectal cancer (CRC) found that a statistically significant...

Genetic Engineering News:  Jul 2 2009 6:22AM
Matching: bites
Find similar documents
HTML
55%
As Fire Ants Continue to Proliferate, Hospital-Proven Burn Anesthetic Brings Instant Relief for Bites, Stings
SAVANNAH, Ga., July 1 /PRNewswire/ -- For some 60 years, fire ants have expanded relentlessly throughout the southern and southwestern United States.

They sting relentlessly, too: first biting the victim's skin with their mandibles (mouth...

Montana's News Station:  Jul 2 2009 1:52AM
Matching: bites
Find similar documents
HTML
55%
As Fire Ants Continue to Proliferate, Hospital-Proven Burn Anesthetic Brings Instant Relief for Bites, Stings
SAVANNAH, Ga., July 1 /PRNewswire/ -- For some 60 years, fire ants have expanded relentlessly throughout the southern and southwestern United States.

They sting relentlessly, too: first biting the victim's skin with their mandibles (mouth...

KLFY:  Jul 1 2009 8:29PM
Matching: bites
Find similar documents
HTML
55%
Genesis Research has gene silencing funding proposal
Source: News Bites Genesis Research and Development Corporation Ltd advised on June 30 that it has received a term sheet for investment in the proposed new subsidiary which will undertake the gene silencing project, as previously...
Business Spectator:  Jul 1 2009 4:25AM
Matching: bites
Find similar documents
HTML
55%
Biotech Capital buys back 5.5k shares
Source: News Bites Biotech Capital Ltd bought back 5,550 shares on market for $888 on June 29, 2009.

It previously bought back 2,124,450 shares.

There are 2,071,975 shares still to be bought back.

STOCK DASHBOARD: July 01, 2009...

Business Spectator:  Jul 1 2009 12:23AM
Matching: bites
Find similar documents
HTML
55%
BioTech Capital buys back 64k shares
Source: News Bites BioTech Capital Ltd bought 64,000 shares worth $10,240 on June 26, 2009.

The company had previously bought back 2,060,450 shares.

There are 2,077,525 shares remaining to be bought back.

STOCK DASHBOARD: June 29...

Business Spectator:  Jun 29 2009 9:18AM
Matching: bites
Find similar documents
HTML
55%
Cephalon International has 93.06% of Arana Therapeutics
Source: News Bites Cephalon International Holdings bought 2,798,331 Arana Therapeutics shares between June 23 and June 26, 2009, via its takeover offer, increasing from 211,619,006 shares (91.85%) to 214,417,337 shares (93.06%).
Business Spectator:  Jun 29 2009 12:37AM
Matching: bites
Find similar documents
HTML
55%
BioTech Capital buys back 32k
Source: News Bites BioTech Capital Ltd bought back 32,500 shares on-market on June 26, 2009.

Previously 2,027,950 shares have been bought back.

There are still 2,141,525 shares to be bought back.

STOCK DASHBOARD: June 26, 2009...

Business Spectator:  Jun 26 2009 10:57AM
Matching: bites
Find similar documents
HTML
55%
Stirling Products to acquire MilPharma
Source: News Bites Stirling Products Ltd will purchase the business of MilPharma Pty Ltd trading as Chess Technology - administrators appointed - subject to certain conditions of sale.

Consideration is $465,000 in cash and shares...

Business Spectator:  Jun 26 2009 8:32AM
Matching: bites
Find similar documents
HTML
55%
BioTech Capital buys back 78k
Source: News Bites BioTech Capital Ltd bought back 78,800 shares on-market on June 25, 2009.

Previously 1,949,150 shares have been bought back.

There are still 2,174,025 shares to be bought back.

STOCK DASHBOARD: June 25, 2009...

Business Spectator:  Jun 25 2009 10:42AM
Matching: bites
Find similar documents
HTML
55%
BioTech Capital buys back 78k
Source: News Bites BioTech Capital Ltd bought back 78,800 shares on-market on June 25, 2009.

Previously 1,949,150 shares have been bought back.

There are still 2,174,025 shares to be bought back.

STOCK DASHBOARD: June 25, 2009...

Business Spectator:  Jun 25 2009 10:41AM
Matching: bites
Find similar documents
HTML
55%
Sigma Pharmaceuticals directors buy plan shares
Source: News Bites Sigma Pharmaceuticals Ltd director William James Scott directly bought 3,682 plan shares for $3,885 on-market on June 18, 2009.

He holds 4,841,609 shares.

Director Brian Jamieson directly bought 8,542 plan shares...

Business Spectator:  Jun 25 2009 8:48AM
Matching: bites
Find similar documents
HTML
55%
Spider Bites (Symptoms)
Medical Author: Medical Editor: Most spiders do not have mouth parts strong enough to penetrate human skin, and the majority of spiders found in the U.S.

and are actually harmless.

There are two notable exceptions, the black widow spider...

MedicineNet.com:  Jun 24 2009 4:01PM
Matching: bites
Find similar documents
HTML
55%
BioTech Capital buys back 18k shares on-market
Source: News Bites BioTech Capital bought back 18,150 shares for $2,904 on-market on June 23.

Previously 1,931,000 shares have been bought back.

There are 2,252,825 shares still to be bought back.

STOCK DASHBOARD: June 24, 2009...

Business Spectator:  Jun 24 2009 11:48AM
Matching: bites
Find similar documents
HTML
55%
Cephalon has 91.85% of Arana Therapeutics
Source: News Bites Cephalon International Holdings bought 5,455,983 Arana Therapeutics shares for $7,638,376 between June 15 and June 22 via its takeover offer, increasing from 206,163,023 shares (90.41%) to 211,619,006 shares (91.85%)...
Business Spectator:  Jun 23 2009 7:32AM
Matching: bites
Find similar documents
HTML
55%
Growing concern over MRSA transmission between pets and their owners
22nd June 2009 AUK Staff 0 vote Much more remains to be learned about MRSA and pet-associated human infections Dr Richard Oehler et al.

A new review, by Dr Richard Oehler et al., of the University of South Florida College of Medicine,...

Anasthesia UK:  Jun 23 2009 2:16AM
Matching: bites
Find similar documents
HTML
55%
BioTech Capital buys back 26k shares
Source: News Bites BioTech Capital Ltd bought back 26,000 shares worth $4,160 on June 22, 2009.

The company had previously bought back 1,905,000 shares.

There are 2,270,975 shares remaining to be bought back.

STOCK DASHBOARD:...

Business Spectator:  Jun 22 2009 11:22AM
Matching: bites
Find similar documents
HTML
55%
Antisense has more positive results on prostate cancer drug
Source: News Bites Antisense Therapeutics Ltd has had further positive results from its collaborative preclinical research studies on the therapeutic potential of ATL1101 in prostate cancer.

In experimental models, ATL1101 treatment...

Business Spectator:  Jun 19 2009 3:45AM
Matching: bites
Find similar documents
HTML
55%
BioTech Capital buys back 20k
Source: News Bites BioTech Capital Ltd bought back 20,000 shares on-market on June 18, 2009.

Previously 1,885,000 shares have been bought back.

There are still 2,296,975 shares to be bought back.

STOCK DASHBOARD: June 18, 2009...

Business Spectator:  Jun 18 2009 11:08AM
Matching: bites
Find similar documents
HTML
55%
Virax recruits more than half needed for HIV vaccine trial
Source: News Bites Virax Holdings Ltd's HIV immunotherapeutic vaccine VIR201 has recruited over 50% of its required trial participants with 74 people signed to date.

Viraz says recruitment has been achieved via three active trial...

Business Spectator:  Jun 17 2009 10:02AM
Matching: bites
Find similar documents
HTML
55%
Biotech Capital buys back 5k shares on-market
Source: News Bites Biotech Capital Ltd bought back 5,000 shares on-market on Jun Biotech Capital buys back 5k shares on-market.
Business Spectator:  Jun 17 2009 3:22AM
Matching: bites
Find similar documents
HTML
55%
BioTech Capital buys back 16k shares
Source: News Bites BioTech Capital Ltd bought back 16,150 shares for $2,584 on-market on June 15, 2009.

Previously 1,863,850 shares have been bought back.

There are 2,321,975 shares still to be bought back.

STOCK DASHBOARD: June...

Business Spectator:  Jun 15 2009 12:06PM
Matching: bites
Find similar documents
HTML
55%
Cephalon has 90.41% of Arana Therapeutics
Source: News Bites Cephalon International bought 3,926,713 Arana Therapeutics shares on June 11 and June 12 via its takeover offer, increasing from 203,496,213 shares (89.24%) to 206,163,023 shares (90.41%).

STOCK DASHBOARD: June 15,...

Business Spectator:  Jun 15 2009 8:57AM
Matching: bites
Find similar documents
HTML
55%
Australian Pharmaceutical Industries director buys on-market
Source: News Bites Australian Pharmaceutical Industries Ltd director Robert Dobson Millner indirectly bought 100,000 shares worth $70,430 on-market on June 9 and 10, 2009.

He indirectly holds 311,000 shares.

STOCK DASHBOARD: June...

Business Spectator:  Jun 15 2009 7:19AM
Matching: bites
Find similar documents
HTML
55%
BioTech buys back 10k shares
Source: News Bites BioTech Capital Ltd bought back 10,000 shares for $1,600 on-market on June 12, 2009.

Previously, the company had bought back 1,853,850 shares.

There are 2,338,125 shares still to be bought back.

STOCK DASHBOARD...

Business Spectator:  Jun 15 2009 6:55AM
Matching: bites
Find similar documents


 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.